As part of the settlement, CVS admitted and accepted responsibility for certain conduct alleged by the government, including ...

Harrow, Inc. has secured a key win as CVS’s pharmacy benefit manager replaced Xiidra with Harrow’s dry eye drug Vevye on its Tier 1 formulary, and the company recently presented at BTIG Ophthalmology ...

Wednesday's mistrial motion, filed by Walmart, Walgreens and CVS, cites the extraordinary length of jury deliberations and ...

CVS settles insulin dispensing case for $38M over improper billing to Medicare, Medicaid and federal health programs from 2010 to 2020.

This milestone event will highlight the newly completed residential spaces inside the Prichard building and showcase the next ...

This milestone event will highlight the newly completed residential spaces inside the Prichard building and showcase the next ...

A record $37.8 million settlement closes a decade-long case alleging that CVS overbilled government health programs by ...

CVS has settled a lawsuit for $37.76 million over claims of over-dispensing insulin pens and fraudulent billing.

As Dr. Siavash Ghoreishi fights for visitation with his granddaughter, he defends the prescriptions he wrote for Shahrzad ...

CVS Health Corporation (NYSE:CVS) is included among the 15 Dividend Stocks that Outperform the S&P 500. On November 13⁠,​ ...

Morgan Stanley reiterated an Overweight rating and $21 price target on Bausch + Lomb (BLCO), saying its CVS (CVS) commercial agreement over Xiidra ...

Two Ventura County residents on probation with outstanding warrants were arrested in connection with a theft from the CVS on ...